Fanconi Anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to Mitomycin C and defective cell cycle progression.
Introduction
Fanconi Anemia (FA) is an autosomal recessive cancer susceptibility syndrome characterized by multiple congenital anomalies and progressive bone marrow failure (reviewed in [1] [2] ). FA cells are sensitive to DNA crosslinking agents, such as mitomycin C (MMC), and, to a lesser extent, ionizing radiation (IR) [3, 4] . Based on somatic cell fusion studies, FA is comprised of eight distinct complementation groups (A, B, C, D1, D2, E, F, G) [5, 6] . Six of the FA genes, including the genes for FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG, have been cloned [6] [7] [8] [9] [10] [11] [12] .
Recent studies have demonstrated that the six cloned FA proteins interact in a common cellular pathway [13] . The FANCA, FANCC, FANCE, FANCF, and FANCG proteins assemble in a multisubunit nuclear complex [14, 15] . This FA protein complex (A/C/E/F/G) is required for the monoubiquitination of the FANCD2 protein, suggesting that the complex functions as a multisubunit monoubiquitin ligase or regulates such an activity. When normal (non-FA) cells are exposed to DNA damaging agents, FANCD2 is monoubiquitinated and targeted to nuclear foci containing BRCA1 [13] . Disruption of this pathway leads to the characteristic cellular and clinical abnormalities observed in FA.
FA cells have a defect in cell cycle progression. First, FA cells lack the ability to delay S phase progression in response to DNA damage from DNA crosslinking agents [16, 17] . Second, FA cells accumulate in the G2 phase of the cell cycle following crosslinker exposure [18] . This G2 delay appears to result from a normal G2/M checkpoint response to excessive DNA damage in the preceding S phase [19] . Third, recent studies demonstrate that FA cells arrest in late S phase following cellular exposure to interstrand crosslinks (ICL), suggesting that the FA pathway helps to repair these crosslinks in S phase [20] [21] .
The recently-demonstrated interaction between FANCD2 and BRCA1 [13] has suggested possible cellular functions of the FA pathway. BRCA1 (-/-) cells are phenotypically similar to FA cells, displaying spontaneous chromosome breakage and MMC or IR sensitivity [22] . BRCA1 (-/-) cells have a defect in an S phase cell cycle checkpoint after IR [23] and have a defect in homology-directed DNA repair (HDR)
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In the current study, we examined the FANCD2 protein during the cell cycle. We found that FANCD2 is monoubiquitinated during the S phase of the cell cycle, and FANCD2/BRCA1 foci and FANCD2/RAD51 foci form during S phase. The monoubiquitination of FANCD2 during S phase is required for normal cell cycle progression following cellular exposure to MMC.
Materials and Methods
Cell lines and culture conditions. The SV40-transformed FA fibroblasts, GM6914 (FA-A) and PD20 (FA-D2), as well as HeLa cells, were grown in DMEM supplemented with 15% heat inactivated fetal calf serum (FCS). GM6914 cells were functionally complemented with pMMP retroviral vectors containing FANCA cDNA, and functional complementation was confirmed by the MMC assay [25] . Stable FA-D2 transfectants (PD20) expressing wild-type FANCD2 or the FANCD2(K561R) mutant were previously described [13] .
Retroviral infection and MMC sensitivity assay. The retroviral expression vector, pMMP-puro [26] , pMMP-puro FANCD2 and pMMP-puro FANCD2K561R [13] were described previously. pMMP-puro-HA-FANCD2(wt) was generated by adding the influenza hemagglutinin (HA) tag (AYPYDVPDYA) at the amino terminus of FANCD2.
Production of pMMP retroviral supernatants and infection of fibroblasts were performed as previously described [25] . After 48 hours, cells were trypsinized and selected in medium containing puromycin (1µg/ml). Cells were analyzed for MMC sensitivity by the crystal violet assay [25] .
Cell cycle synchronization. HeLa cells or the indicated FA fibroblast lines were synchronized by the double thymidine block method as previously described, with minor modifications [27] . Briefly, cells were treated with 2mM thymidine for 18 hours, thymidine-free media for 10 hours and additionally with 2mM thymidine for 18 hours to arrest the cell cycle at the G1/S boundary. Cells were washed twice with PBS and then released in DMEM +15% FCS and analyzed at various time intervals. Alternatively, HeLa cells were treated with 0.5 mM mimosine (Sigma) for 24 hours for synchronization in late G1 phase [28] , washed twice with PBS, and released into DMEM +15% FCS. For synchronization in M phase, a nocodazole block was used [29] . Cells were treated with 0.1 µg/ml nocodazole (Sigma) for 15 hours, and the nonadherent cells were washed twice with PBS and replated in DMEM +15%FCS. ice until analyzed with a FACscan system using Cell Quest Software. Cell aggregates were gated out and 10,000 events were analyzed.
Immunoblotting. Immunoblotting was performed as previously described [13] . Anti-FANCD2 mouse monoclonal antibody FI17 (1:200 dilution) was used as a primary antibody.
Immunofluorescence microscopy. Cells were fixed with 2% paraformaldehyde in PBS for 20 min., followed by permeabilization with 0.3% Triton-X-100 in PBS (10 min).
After blocking in 10% goat serum and 0.1% NP-40 in PBS (blocking buffer), specific antibodies were added at the appropriate dilution in blocking buffer and incubated for 2-4 hours at room temperature. FANCD2 was detected using the affinity-purified E35 polyclonal antibody (1/100) [13] . For BRCA1 detection, we used a commercial monoclonal antibody (D-9, Santa Cruz) at 2 µg/ml. For HA detection, anti-HA (HA.11, Babco) (1:500) antibody was used. Alternatively, the polyclonal anti-RAD51 antibody (Oncogene, Ab-1, 1:800) was used. Cells were subsequently washed three times in PBS + 0.1% NP-40 (10-15 min each wash) and species-specific fluorescein or Texas redconjugated secondary antibodies (Jackson Immunoresearch) were diluted in blocking buffer (anti-mouse 1/700, anti-rabbit 1/700) and added. After 1 hour at room temperature three more 10-15 min washes containing 1 microgram/ml DAPI were applied and the slides were mounted in Vectashield (Vector laboratories). Images were captured on a Nikon microscope and processed using Openlab (Improvision) and Adobe Photoshop software. Colocalization of FANCD2 and BRCA1 was performed as previously described [13] . During G1 phase (6 hours after release from synchronization with nocodazole), only FANCD2-S was detected by immunoblotting, and this protein was distributed in a diffuse nuclear pattern ( Figure 1D, panel c) . When the synchronized cells entered S phase (15 to 18 hours), an increase in FANCD2-L and FANCD2 nuclear foci was observed ( Figure   1D , panels f, g). A similar result was observed in mimosine synchronized cells ( Figure   1E ).
We have previously shown that FA cells from complementation groups A, C, F, and G fail to assemble the FA protein complex and fail to monoubiquitinate FANCD2 in response to DNA damage [13] . We examined the expression of the FANCD2 isoforms in described (data not shown) [13] . The corrected cells demonstrated S phase-specific monoubiquitination of FANCD2 ( Figure 3A) . In contrast, FANCD2 (K561R) was not monoubiquitinated during the cell cycle.
We next analyzed cell cycle progression in the various transfected FA-D2 fibroblast lines (Table 1 and Figure 3B ). Double-thymidine blocked cells were released into S phase, either in the absence or presence of the DNA crosslinking agent, MMC, and analyzed for cell cycle progression. By three hours following release, cells had advanced into S phase to greater than 85%, irrespective of MMC exposure. Uncorrected FA-D2 cells (i.e., transduced with empty vector or with the cDNA encoding FANCD2 (K561R)) and corrected FA cells (i.e., transduced with the wild-type FANCD2 cDNA) showed no difference in S phase duration (Table 1) . Greater than 77% of the synchronized cells had traversed S phase and entered G2/M phase after 8 hours. Exposure to MMC had no obvious effect on S phase duration (8 hours). By 12 hours following release from double thymidine block, in the absence of MMC, many corrected and uncorrected PD20 cells had completed cell division as determined by the reappearance of a G1 peak. However, MMC exposed cells retained a 4N DNA content longer and failed to progress into the G1 phase of the next cell cycle.
To determine whether the 4N arrest following MMC occurred in G2 versus M phase, we used a biparameter flow cytometric assay with MPM-2 antibody (specific for mitotic phosphorylated protein) and DNA content ( Figure 3B ) [30, 31] . Cells with 4N DNA content and high expression of MPM-2 were scored as mitotic cells. In the absence of MMC-induced DNA damage, there was no significant difference in the progression of were synchronized with mimosine, released into S phase, and costained with antisera to FANCD2 and BRCA1. As shown in Figure 4A , during S phase, most FANCD2 foci (70%) overlapped with BRCA1 foci.
We examined the dynamic behavior of FANCD2 and BRCA1 foci in S phase following DNA damage ( Figure 4B ). Treatment of S phase synchronized cells with IR, MMC, or UV resulted in a rapid diffusion of BRCA1 dots, as previously described [32, 33] . FANCD2 dots did not disperse following DNA damage, suggesting that BRCA1 and FANCD2 proteins transiently dissociate in response to DNA damage. The FANCD2 protein is therefore similar to other BRCA1 associated proteins, such as hCds1/Chk2 [33] and CtIP [34] , which transiently dissociate from BRCA1 foci following IR-activated BRCA1 phosphorylation in S phase.
Intera ction of FANCD2 and RAD51 during S phase. The RecA homologue, RAD51, binds single-stranded DNA and, together with BRCA2, is required for homology-directed DNA repair [35] . RAD51 forms nuclear foci during S phase in untreated cells and colocalizes with BRCA1 in ionizing-radiation inducible foci and in S phase foci [36] .
We therefore determined whether the activated (monoubiquitinated) FANCD2 protein colocalizes with RAD51 by performing double immunolabeling in complemented FANCD2 cells ( Figure 5 ). PD20 (FA-D2) fibroblasts cells were stably transfected and At least one subunit (FANCG) of the FA protein complex is cyclically phosphorylated in mitosis [37] , suggesting a possible mechanism of cell cycle dependent modulation of enzyme activity. Second, the FANCD2 protein may become phosphorylated during S phase, rendering it a suitable substrate for monoubiquitination. Consistent with this latter model, the FANCD2 protein is a phosphoprotein, though its specific kinase(s) remain unknown (data not shown).
S phase-specific monoubiquitination and DNA damage-inducible monoubiquitination of FANCD2 appear to be mechanistically distinct. For instance, DNA damage activates FANCD2 monoubiquitination and FANCD2 foci formation even during the G1 phase of the cell cycle (I. Garcia-Higuera, unpublished observation).
Perhaps different upstream kinases activate S phase or DNA-damage inducible monoubiquitination. Like FANCD2, BRCA1 is phosphorylated in S phase or following cellular exposure to DNA damage. Cyclin A/cdk2 activates cell cycle dependent
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Taniguchi T., et al. 12 phosphorylation of BRCA1 [29] and ATM, ATR, and CHK2 activates the DNA damageinducible phosphorylation of BRCA1 [33, [38] [39] [40] . Phosphorylation of BRCA1, resulting from IR induction or S phase progression, may enhance ubiquitin ligase activity and monoubiquitination of FANCD2. Consistent with this model, recent studies have shown that ATM-dependent phosphorylation of another ubiquitin ligase, MDM2, may regulate its ability to ubiquitinate p53 [41] .
As cells enter G2/M, the monoubiquitinated FANCD2-L isoform is no longer detected, suggesting that it is either deubiquitinated or degraded at this stage of the cell cycle. Deubiquitination is more likely than degradation, because (1) Recent studies have demonstrated that the BRCA1 protein is required for homology-directed DNA repair (HDR) [22, 24] . One type of HDR (i.e., gene conversion by sister chromatids) can occur during S phase of the cell cycle [42, 43] . Gene conversion occurs during normal DNA replication [42] and may function to repair replication intermediates (i.e., double strand breaks) which occur normally during S phase. HDR is an error-free mechanism of DNA repair, requires DNA replication and strand invasion by a sister chromatid, and requires RAD51. Consistent with a direct role in homologous recombination, BRCA1 forms foci with RAD51 during normal S phase [36] . For personal use only. on October 19, 2017 . by guest www.bloodjournal.org From
